Literature DB >> 17489965

Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis.

Sachin Mathur1, Edward J Gane, John L McCall, Lindsay D Plank.   

Abstract

BACKGROUND AND AIM: Serum sodium may have prognostic value in addition to the model for end-stage liver disease (MELD) score for prediction of early mortality in patients listed for liver transplant. In patients with cirrhosis, over-hydration is a common feature but its prognostic value has not been evaluated. This study examines the independent prognostic significance of MELD, serum sodium and hydration status on long-term survival in patients with cirrhosis.
METHODS: Serum sodium and hydration (total body water as a percentage of fat-free mass) were measured in 227 consecutive cirrhotic patients (146 male, 81 female; median age 49 years, range 19-73 years; median MELD score 13, range 6-36). Patients with hepatocellular carcinoma or listed for liver transplantation at the time of initial assessment were excluded. A competing risks Cox proportional hazards analysis was performed to evaluate the influence of MELD, sodium and hydration on risk of death or transplant.
RESULTS: Median follow-up was 52 (range 4-93) months. Serum sodium and hydration were each associated with reduction in time to death or transplant on univariate analysis (sodium: hazard ratio [HR] 0.90, 95% confidence interval [CI] 0.87-0.94, P < 0.0001; hydration: HR 1.20, 95% CI 1.10-1.30, P < 0.0001). On multivariate analysis, MELD, serum sodium and hydration were independently predictive of death or transplant (MELD: HR 1.12, 95% CI 1.06-1.19, P < 0.0001; sodium: HR 0.93, 95% CI 0.87-0.99, P = 0.04; hydration: HR 1.17, 95% CI 1.02-1.33, P = 0.02).
CONCLUSIONS: In non-waitlisted patients with cirrhosis, serum sodium is predictive of transplant or death independent of MELD score.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17489965     DOI: 10.1111/j.1440-1746.2007.04891.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  2 in total

1.  New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt.

Authors:  Jennifer Guy; Ma Somsouk; Stephen Shiboski; Robert Kerlan; John M Inadomi; Scott W Biggins
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-26       Impact factor: 11.382

2.  Model for End-Stage Liver Disease and liver cirrhosis-related complications.

Authors:  Luis Calzadilla Bertot; Eduardo Vilar Gomez; Linnet Alonso Almeida; Enrique Arus Soler; Luis Blanco Perez
Journal:  Hepatol Int       Date:  2012-10-10       Impact factor: 6.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.